Julex Capital Management’s Surmodics SRDX Stock Holding History

Julex Capital Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12	Closed	-$521	–	212
2019 Q1	$521	Hold	12	–	–	﹤0.01%	143
2018 Q4	$0	Buy	+12	New	+$720	﹤0.01%	122

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Julex Capital Management's SRDX Position: Q2 2019 in Review

Julex Capital Management sold out of Surmodics (SRDX) in Q2 2019, closing a stake of 12 shares — an estimated $521 sold.

Julex Capital Management first reported a position in SRDX in Q4 2018 and held it in 2 quarters. The position peaked at $521 in Q1 2019. 140 funds tracked by Wall St. Rank hold SRDX as of Q2 2019.

Julex Capital Management reported no remaining Surmodics position as of Q2 2019 after selling out during the quarter.
Julex Capital Management sold 12 Surmodics shares in Q2 2019, an estimated $521.
Julex Capital Management first reported a position in Surmodics in Q4 2018 and held it in 2 quarters.
Julex Capital Management's Surmodics position peaked at $521 in Q1 2019.
140 funds tracked by Wall St. Rank held Surmodics as of Q2 2019.

Based on Julex Capital Management's 13F filing for Q2 2019, filed 29 Oct 2019.